Navigation Links
Fate Therapeutics announces creation of small molecule platform for commercial-scale reprogramming
Date:10/18/2009

La Jolla, CA October 18, 2009 Fate Therapeutics, Inc. announced today the generation of human induced-pluripotent stem cells (iPSCs) using a combination of small molecules that significantly improves the speed and efficiency of reprogramming. The discoveries, which were made by Sheng Ding, Ph.D. under a research collaboration between Fate Therapeutics and The Scripps Research Institute (TSRI), represent a more than 200-fold improvement in reprogramming efficiency and reduce the reprogramming period to two weeks as compared to methods using only the four reprogramming factors (Oct 3/4, Sox2, Klf4 and c-Myc). This latest advancement has broad implications for the creation of "pharmaceutical grade" iPSCs, reprogrammed cells that can be produced without genetic modification at commercial scale quantity, quality and consistency and continues to bolster the leadership position of Fate Therapeutics in industrialized iPSC technology. The Company is developing minimally invasive techniques for reprogramming and differentiation and has exclusively in-licensed from TSRI and the Whitehead Institute for Biomedical Research a intellectual property portfolio related to iPSC technology dating back to November 2003.

"While recent studies have reported improved methods of reprogramming, those techniques have relied on further genetic manipulation or have not otherwise addressed a fundamental reprogramming challenge that iPSC generation is still a very slow and inefficient process and results in a heterogeneous population of cells," said Paul Grayson, president & CEO of Fate Therapeutics. "Once again, Dr. Ding and his team are the first group to clear yet another major hurdle required for the widespread commercial use of iPSCs for drug discovery and patient therapies."

The findings of Dr. Ding and his colleagues are published today in the Advanced Online edition of the scientific journal Nature Methods. As compared to using the four reprogram
'/>"/>

Contact: Cory Tromblee
ctromblee@macbiocom.com
617-571-7220
MacDougall Biomedical Communications, Inc.
Source:Eurekalert

2

GOOD

Page: 1 2

Related biology news :

1. AACR, NCI and EORTC to host molecular targets and cancer therapeutics conference
2. Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development
3. Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
4. Continuous glucose monitoring technology -- special issue of Diabetes Technology and Therapeutics
5. NIH announces new program to develop therapeutics for rare and neglected diseases
6. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
7. Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
8. Acorda Therapeutics submits new drug application for Fampridine-SR in multiple sclerosis
9. A novel target for therapeutics against Staph infection
10. Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration
11. Growing fuel and medicine: Advancing biofuels and plant-produced therapeutics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...h 2009 - Bacteria possess an ingenious mechanism f...cks of the cell. This is the new finding of a team... a life sciences research institute in Flanders, B...l. The scientists made this discovery by modifying...coli . By means of this model organism, they have ...
(Date:11/20/2009)...ulmonary disease (COPD), a respiratory disease com... the fourth leading cause of death worldwide. 600...rs have yet to find any real treatment or cure, Gr...niversity of Western Ontario in London, Canada, is...ght into the disease. , Parraga is a scienti...
(Date:11/19/2009)...rring brain chemical with an unwieldy name: 4-hydr...ed or used as a date-rape drug. , Now, a team o... routes by which 4-HB is metabolized by the body. ...ichael Gibson, professor and chair of biological s... member of the research team. "It may provide new...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Gaining a better picture of lung disease 2Researchers begin to decipher metabolism of sexual assault drug 2Adam Kluger Public Relations Adds Sex Therapist and Psychiatrist Dr Dennis Lin MD to Their All Star Health and Medical Client Roster 60057 1Adam Kluger Public Relations Adds Sex Therapist and Psychiatrist Dr Dennis Lin MD to Their All Star Health and Medical Client Roster 60057 2AMERIGROUP Announces Preliminary Third Quarter Results 60054 1AMERIGROUP Announces Preliminary Third Quarter Results 60054 2AMERIGROUP Announces Preliminary Third Quarter Results 60054 3AMERIGROUP Announces Preliminary Third Quarter Results 60054 4AMERIGROUP Announces Preliminary Third Quarter Results 60054 5Insure com Inc Announces Name Change to Life Quotes Inc and Nasdaq Ticker Symbol Change to QUOT Effective October 28 2009 60051 1Insure com Inc Announces Name Change to Life Quotes Inc and Nasdaq Ticker Symbol Change to QUOT Effective October 28 2009 60051 2
...ntain codeine may be risky for some,breastfeeding ...y of Western Ontario, and the Hospital for Sick Ch...on Koren published research in the journal, Clini...at the codeine used in some pain relief drugs can ...nfants when ingested by some breastfeeding mothers...
...genetic code of a simple saltwater creature could ...nes function in humans and other species. , A stu...aks down the genetic code of Trichoplax , a simpl...in the world, even in the common household aquariu...x , genes that are also found in other animals - o...
...ide algae, Karenia brevis, costs approximately $20...t of Florida alone. Scientists at the Georgia Inst...educe the levels of the red tide,s toxicity to ani...s toxicity to other algae as well. If scientists c...y of red tide, they could reduce the vast amount o...
Other Biology News:Codeine not safe for all breastfeeding moms and their babies 2Genome of saltwater creature could aid understanding of gene grouping 2Biologists find diatom to reduce red tide's toxicity 2Biologists find diatom to reduce red tide's toxicity 3
(Date:11/19/2009)...NSTER, Germany, November 19 MONITO...November 16th, 2009 Flibanserin in the,indication ...Parkinson,s,disease for orphan drug status designa...vodopa-induced dyskinesia is a complication of the...serious burden to some of those,affected, since it...
(Date:11/19/2009)... InSound is honored by latest award for revol...ewark, CA (PRWEB) November 16, 2009 -- Popular Sci...” hearing aid from InSound Medical a winner ...he Health category.    Chosen ...eside deep in the hearing canal for up to four mon...
(Date:11/18/2009)...nnel need to be able to find explosive materials a...aid such searches, the National Institute of Stand...Department of Homeland Security, has developed a n...e Material (SRM) 2905, Trace Particulate Explosive...ods, the SRM will be helpful in calibrating, testi...
(Date:11/18/2009)...r,s experience in data analysis combined with Bio-... kits and curricula provide state-of-the-art so...ON, Ore., Nov. 18 Vernier Software...ce interfaces, sensors, and software and Bio-Rad L...d distributor of life science research and clinica...
Breaking Biology Technology:MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3New NIST trace explosives standard slated for homeland security duty 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2
... Sept. 18 Ingenuity Systems, the,leading provider...cientific,literature and data, is pleased to annou... major public-private biomedical research,partners...biological,markers to support new drug development...he founding members of the Consortium include the ...
...er 18 - Clinical Study Demonstrates Breakthrough... Capacities and Expands Potential Production,Capac... Sanofi pasteur, the vaccines division of sanofi-...ts new investigational H5N1 pandemic influenza,vac...high immune response,at the lowest dose of H5N1 an...
...e University of Pennsylvania have developed nanowi...ears and retrieving that data a thousand times fas...Flash memory and micro-drives, all using less powe...tesh Agarwal, an assistant professor in the Depart...leagues developed a self-assembling nanowire of ge...
Other Biology Technology:Ingenuity Systems Joins Biomarkers Consortium 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 3Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 4Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 5Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 2Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 3
...ou need a partner who can put you on the fast trac... solutions to help accelerate your research. Thats...tion offers a liquid handling platform thats as ad...ts of liquid handling into a single, automated sys...
...0 rabbit tissue samples arrayed on Superfrost Plus...ned slides and 1 hematoxylin and eosin (H&E) stain...5 different tissues from 4 rabbit organisms, for a... sample (or core) is 1.5 mm in diameter. The type ...
...with a wide variety of purity levels, scales and m...rity: IG(>50%), >70%, >80% and >95% Yield: 2mg...ications: Biotin, Fluorescein, N-acetylation, C-a...H/BSA conjugation, and much more. See Modificatio...
Human CALCA EIA (Enzyme immunoassay) Kit, Host: Rabbit ; Extraction-free from BACHEM
Biology Products: